nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefotaxime—Nephritis interstitial—Medroxyprogesterone Acetate—uterine cancer	0.0213	0.0221	CcSEcCtD
Cefotaxime—Cholestasis—Progesterone—uterine cancer	0.0209	0.0217	CcSEcCtD
Cefotaxime—Tubulointerstitial nephritis—Medroxyprogesterone Acetate—uterine cancer	0.0188	0.0195	CcSEcCtD
Cefotaxime—Tenderness—Progesterone—uterine cancer	0.0182	0.0189	CcSEcCtD
Cefotaxime—Induration—Etoposide—uterine cancer	0.0182	0.0189	CcSEcCtD
Cefotaxime—Tenderness—Medroxyprogesterone Acetate—uterine cancer	0.0165	0.0171	CcSEcCtD
Cefotaxime—Vaginal inflammation—Progesterone—uterine cancer	0.0159	0.0165	CcSEcCtD
Cefotaxime—Vaginal infection—Progesterone—uterine cancer	0.015	0.0156	CcSEcCtD
Cefotaxime—Vaginal inflammation—Medroxyprogesterone Acetate—uterine cancer	0.0144	0.0149	CcSEcCtD
Cefotaxime—Nephropathy toxic—Etoposide—uterine cancer	0.0142	0.0147	CcSEcCtD
Cefotaxime—Injection site inflammation—Epirubicin—uterine cancer	0.0137	0.0142	CcSEcCtD
Cefotaxime—Vaginal infection—Medroxyprogesterone Acetate—uterine cancer	0.0136	0.0141	CcSEcCtD
Cefotaxime—Hepatic function abnormal—Progesterone—uterine cancer	0.0132	0.0137	CcSEcCtD
Cefotaxime—Injection site inflammation—Doxorubicin—uterine cancer	0.0126	0.0131	CcSEcCtD
Cefotaxime—Hepatic function abnormal—Medroxyprogesterone Acetate—uterine cancer	0.012	0.0124	CcSEcCtD
Cefotaxime—Haemolytic anaemia—Medroxyprogesterone Acetate—uterine cancer	0.0116	0.012	CcSEcCtD
Cefotaxime—Bullous eruption—Epirubicin—uterine cancer	0.0115	0.012	CcSEcCtD
Cefotaxime—Bullous eruption—Doxorubicin—uterine cancer	0.0107	0.0111	CcSEcCtD
Cefotaxime—Aplastic anaemia—Dactinomycin—uterine cancer	0.0106	0.0109	CcSEcCtD
Cefotaxime—Pain—Carboplatin—uterine cancer	0.00924	0.00958	CcSEcCtD
Cefotaxime—Bronchospasm—Medroxyprogesterone Acetate—uterine cancer	0.00889	0.00923	CcSEcCtD
Cefotaxime—Jaundice—Progesterone—uterine cancer	0.00867	0.009	CcSEcCtD
Cefotaxime—Body temperature increased—Carboplatin—uterine cancer	0.00854	0.00886	CcSEcCtD
Cefotaxime—Local reaction—Epirubicin—uterine cancer	0.00824	0.00854	CcSEcCtD
Cefotaxime—Haemoglobin—Progesterone—uterine cancer	0.00803	0.00833	CcSEcCtD
Cefotaxime—Haemorrhage—Progesterone—uterine cancer	0.00799	0.00828	CcSEcCtD
Cefotaxime—Hepatitis—Progesterone—uterine cancer	0.00799	0.00828	CcSEcCtD
Cefotaxime—Jaundice—Medroxyprogesterone Acetate—uterine cancer	0.00786	0.00815	CcSEcCtD
Cefotaxime—Candida infection—Etoposide—uterine cancer	0.00777	0.00806	CcSEcCtD
Cefotaxime—Local reaction—Doxorubicin—uterine cancer	0.00762	0.00791	CcSEcCtD
Cefotaxime—Erythema multiforme—Progesterone—uterine cancer	0.00755	0.00783	CcSEcCtD
Cefotaxime—Toxic epidermal necrolysis—Dactinomycin—uterine cancer	0.00735	0.00762	CcSEcCtD
Cefotaxime—Haemoglobin—Medroxyprogesterone Acetate—uterine cancer	0.00727	0.00755	CcSEcCtD
Cefotaxime—Hepatitis—Medroxyprogesterone Acetate—uterine cancer	0.00724	0.00751	CcSEcCtD
Cefotaxime—Haemorrhage—Medroxyprogesterone Acetate—uterine cancer	0.00724	0.00751	CcSEcCtD
Cefotaxime—Erythema multiforme—Medroxyprogesterone Acetate—uterine cancer	0.00684	0.0071	CcSEcCtD
Cefotaxime—Neutropenia—Dactinomycin—uterine cancer	0.00659	0.00684	CcSEcCtD
Cefotaxime—Ill-defined disorder—Progesterone—uterine cancer	0.00645	0.00669	CcSEcCtD
Cefotaxime—Angioedema—Progesterone—uterine cancer	0.00635	0.00659	CcSEcCtD
Cefotaxime—Malaise—Progesterone—uterine cancer	0.00627	0.0065	CcSEcCtD
Cefotaxime—Stevens-Johnson syndrome—Dactinomycin—uterine cancer	0.00623	0.00647	CcSEcCtD
Cefotaxime—Convulsion—Progesterone—uterine cancer	0.00602	0.00625	CcSEcCtD
Cefotaxime—Agranulocytosis—Dactinomycin—uterine cancer	0.00587	0.00609	CcSEcCtD
Cefotaxime—Discomfort—Progesterone—uterine cancer	0.00585	0.00607	CcSEcCtD
Cefotaxime—Ill-defined disorder—Medroxyprogesterone Acetate—uterine cancer	0.00584	0.00606	CcSEcCtD
Cefotaxime—Angioedema—Medroxyprogesterone Acetate—uterine cancer	0.00576	0.00597	CcSEcCtD
Cefotaxime—Malaise—Medroxyprogesterone Acetate—uterine cancer	0.00568	0.00589	CcSEcCtD
Cefotaxime—Anaphylactic shock—Progesterone—uterine cancer	0.00567	0.00589	CcSEcCtD
Cefotaxime—Hepatitis—Dactinomycin—uterine cancer	0.00564	0.00586	CcSEcCtD
Cefotaxime—Shock—Progesterone—uterine cancer	0.00558	0.00579	CcSEcCtD
Cefotaxime—Convulsion—Medroxyprogesterone Acetate—uterine cancer	0.00546	0.00566	CcSEcCtD
Cefotaxime—Liver injury—Epirubicin—uterine cancer	0.00542	0.00562	CcSEcCtD
Cefotaxime—Erythema multiforme—Dactinomycin—uterine cancer	0.00534	0.00554	CcSEcCtD
Cefotaxime—Toxic epidermal necrolysis—Etoposide—uterine cancer	0.00532	0.00552	CcSEcCtD
Cefotaxime—Discomfort—Medroxyprogesterone Acetate—uterine cancer	0.0053	0.0055	CcSEcCtD
Cefotaxime—Anaphylactic shock—Medroxyprogesterone Acetate—uterine cancer	0.00514	0.00533	CcSEcCtD
Cefotaxime—Shock—Medroxyprogesterone Acetate—uterine cancer	0.00506	0.00525	CcSEcCtD
Cefotaxime—Thrombocytopenia—Medroxyprogesterone Acetate—uterine cancer	0.00503	0.00522	CcSEcCtD
Cefotaxime—Bronchospasm—Etoposide—uterine cancer	0.00502	0.00521	CcSEcCtD
Cefotaxime—Liver injury—Doxorubicin—uterine cancer	0.00501	0.0052	CcSEcCtD
Cefotaxime—Pain—Progesterone—uterine cancer	0.00485	0.00503	CcSEcCtD
Cefotaxime—Neutropenia—Etoposide—uterine cancer	0.00477	0.00495	CcSEcCtD
Cefotaxime—Feeling abnormal—Progesterone—uterine cancer	0.00468	0.00485	CcSEcCtD
Cefotaxime—Gastrointestinal pain—Progesterone—uterine cancer	0.00464	0.00481	CcSEcCtD
Cefotaxime—Vaginal inflammation—Epirubicin—uterine cancer	0.00456	0.00473	CcSEcCtD
Cefotaxime—Ill-defined disorder—Dactinomycin—uterine cancer	0.00456	0.00473	CcSEcCtD
Cefotaxime—Stevens-Johnson syndrome—Etoposide—uterine cancer	0.00451	0.00468	CcSEcCtD
Cefotaxime—Urticaria—Progesterone—uterine cancer	0.00451	0.00468	CcSEcCtD
Cefotaxime—Abdominal pain—Progesterone—uterine cancer	0.00449	0.00465	CcSEcCtD
Cefotaxime—Body temperature increased—Progesterone—uterine cancer	0.00449	0.00465	CcSEcCtD
Cefotaxime—Renal failure—Etoposide—uterine cancer	0.00447	0.00464	CcSEcCtD
Cefotaxime—Jaundice—Etoposide—uterine cancer	0.00444	0.0046	CcSEcCtD
Cefotaxime—Malaise—Dactinomycin—uterine cancer	0.00443	0.0046	CcSEcCtD
Cefotaxime—Leukopenia—Dactinomycin—uterine cancer	0.0044	0.00456	CcSEcCtD
Cefotaxime—Colitis—Epirubicin—uterine cancer	0.00438	0.00454	CcSEcCtD
Cefotaxime—Candida infection—Epirubicin—uterine cancer	0.00435	0.00452	CcSEcCtD
Cefotaxime—Vaginal infection—Epirubicin—uterine cancer	0.00431	0.00447	CcSEcCtD
Cefotaxime—Aplastic anaemia—Epirubicin—uterine cancer	0.00428	0.00444	CcSEcCtD
Cefotaxime—Agranulocytosis—Etoposide—uterine cancer	0.00425	0.00441	CcSEcCtD
Cefotaxime—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.00424	0.0044	CcSEcCtD
Cefotaxime—Vaginal inflammation—Doxorubicin—uterine cancer	0.00422	0.00438	CcSEcCtD
Cefotaxime—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	0.0042	0.00436	CcSEcCtD
Cefotaxime—Hypersensitivity—Progesterone—uterine cancer	0.00418	0.00434	CcSEcCtD
Cefotaxime—Discomfort—Dactinomycin—uterine cancer	0.00413	0.00429	CcSEcCtD
Cefotaxime—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.00408	0.00424	CcSEcCtD
Cefotaxime—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.00406	0.00422	CcSEcCtD
Cefotaxime—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.00406	0.00422	CcSEcCtD
Cefotaxime—Colitis—Doxorubicin—uterine cancer	0.00405	0.0042	CcSEcCtD
Cefotaxime—Candida infection—Doxorubicin—uterine cancer	0.00403	0.00418	CcSEcCtD
Cefotaxime—Pruritus—Progesterone—uterine cancer	0.00401	0.00416	CcSEcCtD
Cefotaxime—Vaginal infection—Doxorubicin—uterine cancer	0.00398	0.00413	CcSEcCtD
Cefotaxime—Aplastic anaemia—Doxorubicin—uterine cancer	0.00396	0.00411	CcSEcCtD
Cefotaxime—Thrombocytopenia—Dactinomycin—uterine cancer	0.00393	0.00407	CcSEcCtD
Cefotaxime—Diarrhoea—Progesterone—uterine cancer	0.00388	0.00403	CcSEcCtD
Cefotaxime—Erythema multiforme—Etoposide—uterine cancer	0.00386	0.00401	CcSEcCtD
Cefotaxime—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.00379	0.00393	CcSEcCtD
Cefotaxime—Hepatic function abnormal—Epirubicin—uterine cancer	0.00379	0.00393	CcSEcCtD
Cefotaxime—SLC22A11—renal system—uterine cancer	0.00366	0.101	CbGeAlD
Cefotaxime—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.00364	0.00377	CcSEcCtD
Cefotaxime—Vomiting—Progesterone—uterine cancer	0.00361	0.00374	CcSEcCtD
Cefotaxime—Rash—Progesterone—uterine cancer	0.00358	0.00371	CcSEcCtD
Cefotaxime—Dermatitis—Progesterone—uterine cancer	0.00357	0.00371	CcSEcCtD
Cefotaxime—SLC22A7—renal system—uterine cancer	0.00357	0.0991	CbGeAlD
Cefotaxime—Headache—Progesterone—uterine cancer	0.00355	0.00369	CcSEcCtD
Cefotaxime—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.00352	0.00365	CcSEcCtD
Cefotaxime—Hepatic function abnormal—Doxorubicin—uterine cancer	0.0035	0.00364	CcSEcCtD
Cefotaxime—Renal impairment—Epirubicin—uterine cancer	0.00348	0.00361	CcSEcCtD
Cefotaxime—Dermatitis bullous—Epirubicin—uterine cancer	0.00346	0.00359	CcSEcCtD
Cefotaxime—Pain—Dactinomycin—uterine cancer	0.00343	0.00356	CcSEcCtD
Cefotaxime—Nausea—Progesterone—uterine cancer	0.00337	0.0035	CcSEcCtD
Cefotaxime—Feeling abnormal—Dactinomycin—uterine cancer	0.0033	0.00343	CcSEcCtD
Cefotaxime—Ill-defined disorder—Etoposide—uterine cancer	0.0033	0.00342	CcSEcCtD
Cefotaxime—Gastrointestinal pain—Dactinomycin—uterine cancer	0.00328	0.0034	CcSEcCtD
Cefotaxime—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.00327	0.00339	CcSEcCtD
Cefotaxime—Rash—Medroxyprogesterone Acetate—uterine cancer	0.00324	0.00336	CcSEcCtD
Cefotaxime—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.00324	0.00336	CcSEcCtD
Cefotaxime—Headache—Medroxyprogesterone Acetate—uterine cancer	0.00322	0.00334	CcSEcCtD
Cefotaxime—Renal impairment—Doxorubicin—uterine cancer	0.00322	0.00334	CcSEcCtD
Cefotaxime—Malaise—Etoposide—uterine cancer	0.00321	0.00333	CcSEcCtD
Cefotaxime—Dermatitis bullous—Doxorubicin—uterine cancer	0.0032	0.00332	CcSEcCtD
Cefotaxime—Leukopenia—Etoposide—uterine cancer	0.00318	0.0033	CcSEcCtD
Cefotaxime—Body temperature increased—Dactinomycin—uterine cancer	0.00317	0.00329	CcSEcCtD
Cefotaxime—Abdominal pain—Dactinomycin—uterine cancer	0.00317	0.00329	CcSEcCtD
Cefotaxime—SLC15A1—epithelium—uterine cancer	0.00309	0.0858	CbGeAlD
Cefotaxime—Convulsion—Etoposide—uterine cancer	0.00308	0.0032	CcSEcCtD
Cefotaxime—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.00305	0.00317	CcSEcCtD
Cefotaxime—Discomfort—Etoposide—uterine cancer	0.00299	0.0031	CcSEcCtD
Cefotaxime—Toxic epidermal necrolysis—Epirubicin—uterine cancer	0.00298	0.00309	CcSEcCtD
Cefotaxime—Hypersensitivity—Dactinomycin—uterine cancer	0.00295	0.00307	CcSEcCtD
Cefotaxime—SLC22A11—female reproductive system—uterine cancer	0.00293	0.0813	CbGeAlD
Cefotaxime—Anaphylactic shock—Etoposide—uterine cancer	0.0029	0.00301	CcSEcCtD
Cefotaxime—SLC15A1—renal system—uterine cancer	0.00287	0.0796	CbGeAlD
Cefotaxime—Thrombocytopenia—Etoposide—uterine cancer	0.00284	0.00295	CcSEcCtD
Cefotaxime—Eosinophilia—Epirubicin—uterine cancer	0.00283	0.00294	CcSEcCtD
Cefotaxime—SLC15A1—endometrium—uterine cancer	0.00277	0.077	CbGeAlD
Cefotaxime—Toxic epidermal necrolysis—Doxorubicin—uterine cancer	0.00276	0.00286	CcSEcCtD
Cefotaxime—Diarrhoea—Dactinomycin—uterine cancer	0.00274	0.00285	CcSEcCtD
Cefotaxime—SLC15A1—mammalian vulva—uterine cancer	0.00268	0.0744	CbGeAlD
Cefotaxime—Neutropenia—Epirubicin—uterine cancer	0.00268	0.00278	CcSEcCtD
Cefotaxime—Eosinophilia—Doxorubicin—uterine cancer	0.00262	0.00272	CcSEcCtD
Cefotaxime—Vomiting—Dactinomycin—uterine cancer	0.00255	0.00265	CcSEcCtD
Cefotaxime—Stevens-Johnson syndrome—Epirubicin—uterine cancer	0.00253	0.00262	CcSEcCtD
Cefotaxime—Rash—Dactinomycin—uterine cancer	0.00253	0.00262	CcSEcCtD
Cefotaxime—Renal failure—Epirubicin—uterine cancer	0.00251	0.0026	CcSEcCtD
Cefotaxime—Jaundice—Epirubicin—uterine cancer	0.00249	0.00258	CcSEcCtD
Cefotaxime—Pain—Etoposide—uterine cancer	0.00248	0.00257	CcSEcCtD
Cefotaxime—Neutropenia—Doxorubicin—uterine cancer	0.00248	0.00257	CcSEcCtD
Cefotaxime—Feeling abnormal—Etoposide—uterine cancer	0.00239	0.00248	CcSEcCtD
Cefotaxime—Nausea—Dactinomycin—uterine cancer	0.00238	0.00247	CcSEcCtD
Cefotaxime—Agranulocytosis—Epirubicin—uterine cancer	0.00238	0.00247	CcSEcCtD
Cefotaxime—Gastrointestinal pain—Etoposide—uterine cancer	0.00237	0.00246	CcSEcCtD
Cefotaxime—Stevens-Johnson syndrome—Doxorubicin—uterine cancer	0.00234	0.00243	CcSEcCtD
Cefotaxime—Renal failure—Doxorubicin—uterine cancer	0.00232	0.00241	CcSEcCtD
Cefotaxime—Urticaria—Etoposide—uterine cancer	0.00231	0.00239	CcSEcCtD
Cefotaxime—Haemoglobin—Epirubicin—uterine cancer	0.0023	0.00239	CcSEcCtD
Cefotaxime—Jaundice—Doxorubicin—uterine cancer	0.0023	0.00239	CcSEcCtD
Cefotaxime—Body temperature increased—Etoposide—uterine cancer	0.00229	0.00238	CcSEcCtD
Cefotaxime—Abdominal pain—Etoposide—uterine cancer	0.00229	0.00238	CcSEcCtD
Cefotaxime—Hepatitis—Epirubicin—uterine cancer	0.00229	0.00238	CcSEcCtD
Cefotaxime—Haemorrhage—Epirubicin—uterine cancer	0.00229	0.00238	CcSEcCtD
Cefotaxime—Agranulocytosis—Doxorubicin—uterine cancer	0.0022	0.00229	CcSEcCtD
Cefotaxime—Erythema multiforme—Epirubicin—uterine cancer	0.00217	0.00225	CcSEcCtD
Cefotaxime—Hypersensitivity—Etoposide—uterine cancer	0.00214	0.00222	CcSEcCtD
Cefotaxime—Haemoglobin—Doxorubicin—uterine cancer	0.00213	0.00221	CcSEcCtD
Cefotaxime—Haemorrhage—Doxorubicin—uterine cancer	0.00212	0.0022	CcSEcCtD
Cefotaxime—Hepatitis—Doxorubicin—uterine cancer	0.00212	0.0022	CcSEcCtD
Cefotaxime—SLC15A1—vagina—uterine cancer	0.00208	0.0577	CbGeAlD
Cefotaxime—SLC22A8—renal system—uterine cancer	0.00206	0.0573	CbGeAlD
Cefotaxime—Pruritus—Etoposide—uterine cancer	0.00205	0.00213	CcSEcCtD
Cefotaxime—Arrhythmia—Epirubicin—uterine cancer	0.00205	0.00212	CcSEcCtD
Cefotaxime—Erythema multiforme—Doxorubicin—uterine cancer	0.002	0.00208	CcSEcCtD
Cefotaxime—Diarrhoea—Etoposide—uterine cancer	0.00199	0.00206	CcSEcCtD
Cefotaxime—SLC15A2—uterine cervix—uterine cancer	0.00192	0.0532	CbGeAlD
Cefotaxime—Arrhythmia—Doxorubicin—uterine cancer	0.00189	0.00196	CcSEcCtD
Cefotaxime—Ill-defined disorder—Epirubicin—uterine cancer	0.00185	0.00192	CcSEcCtD
Cefotaxime—Vomiting—Etoposide—uterine cancer	0.00185	0.00191	CcSEcCtD
Cefotaxime—Rash—Etoposide—uterine cancer	0.00183	0.0019	CcSEcCtD
Cefotaxime—Dermatitis—Etoposide—uterine cancer	0.00183	0.0019	CcSEcCtD
Cefotaxime—Headache—Etoposide—uterine cancer	0.00182	0.00189	CcSEcCtD
Cefotaxime—Malaise—Epirubicin—uterine cancer	0.0018	0.00186	CcSEcCtD
Cefotaxime—SLC15A2—renal system—uterine cancer	0.00179	0.0498	CbGeAlD
Cefotaxime—Leukopenia—Epirubicin—uterine cancer	0.00178	0.00185	CcSEcCtD
Cefotaxime—SLC15A2—endometrium—uterine cancer	0.00173	0.0481	CbGeAlD
Cefotaxime—Convulsion—Epirubicin—uterine cancer	0.00173	0.00179	CcSEcCtD
Cefotaxime—Nausea—Etoposide—uterine cancer	0.00172	0.00179	CcSEcCtD
Cefotaxime—Ill-defined disorder—Doxorubicin—uterine cancer	0.00171	0.00178	CcSEcCtD
Cefotaxime—Discomfort—Epirubicin—uterine cancer	0.00168	0.00174	CcSEcCtD
Cefotaxime—Malaise—Doxorubicin—uterine cancer	0.00166	0.00173	CcSEcCtD
Cefotaxime—Leukopenia—Doxorubicin—uterine cancer	0.00165	0.00171	CcSEcCtD
Cefotaxime—Anaphylactic shock—Epirubicin—uterine cancer	0.00163	0.00169	CcSEcCtD
Cefotaxime—Shock—Epirubicin—uterine cancer	0.0016	0.00166	CcSEcCtD
Cefotaxime—Convulsion—Doxorubicin—uterine cancer	0.0016	0.00166	CcSEcCtD
Cefotaxime—Thrombocytopenia—Epirubicin—uterine cancer	0.00159	0.00165	CcSEcCtD
Cefotaxime—Discomfort—Doxorubicin—uterine cancer	0.00155	0.00161	CcSEcCtD
Cefotaxime—Anaphylactic shock—Doxorubicin—uterine cancer	0.00151	0.00156	CcSEcCtD
Cefotaxime—Shock—Doxorubicin—uterine cancer	0.00148	0.00154	CcSEcCtD
Cefotaxime—Thrombocytopenia—Doxorubicin—uterine cancer	0.00147	0.00153	CcSEcCtD
Cefotaxime—SLC15A2—female reproductive system—uterine cancer	0.00144	0.0399	CbGeAlD
Cefotaxime—Pain—Epirubicin—uterine cancer	0.00139	0.00144	CcSEcCtD
Cefotaxime—Feeling abnormal—Epirubicin—uterine cancer	0.00134	0.00139	CcSEcCtD
Cefotaxime—Gastrointestinal pain—Epirubicin—uterine cancer	0.00133	0.00138	CcSEcCtD
Cefotaxime—SLC15A2—female gonad—uterine cancer	0.00131	0.0363	CbGeAlD
Cefotaxime—SLC15A2—vagina—uterine cancer	0.0013	0.036	CbGeAlD
Cefotaxime—Urticaria—Epirubicin—uterine cancer	0.00129	0.00134	CcSEcCtD
Cefotaxime—Pain—Doxorubicin—uterine cancer	0.00129	0.00134	CcSEcCtD
Cefotaxime—Abdominal pain—Epirubicin—uterine cancer	0.00129	0.00133	CcSEcCtD
Cefotaxime—Body temperature increased—Epirubicin—uterine cancer	0.00129	0.00133	CcSEcCtD
Cefotaxime—Feeling abnormal—Doxorubicin—uterine cancer	0.00124	0.00129	CcSEcCtD
Cefotaxime—Gastrointestinal pain—Doxorubicin—uterine cancer	0.00123	0.00128	CcSEcCtD
Cefotaxime—Hypersensitivity—Epirubicin—uterine cancer	0.0012	0.00124	CcSEcCtD
Cefotaxime—Urticaria—Doxorubicin—uterine cancer	0.0012	0.00124	CcSEcCtD
Cefotaxime—Abdominal pain—Doxorubicin—uterine cancer	0.00119	0.00123	CcSEcCtD
Cefotaxime—Body temperature increased—Doxorubicin—uterine cancer	0.00119	0.00123	CcSEcCtD
Cefotaxime—Pruritus—Epirubicin—uterine cancer	0.00115	0.00119	CcSEcCtD
Cefotaxime—Diarrhoea—Epirubicin—uterine cancer	0.00111	0.00115	CcSEcCtD
Cefotaxime—Hypersensitivity—Doxorubicin—uterine cancer	0.00111	0.00115	CcSEcCtD
Cefotaxime—Pruritus—Doxorubicin—uterine cancer	0.00107	0.0011	CcSEcCtD
Cefotaxime—Vomiting—Epirubicin—uterine cancer	0.00103	0.00107	CcSEcCtD
Cefotaxime—Diarrhoea—Doxorubicin—uterine cancer	0.00103	0.00107	CcSEcCtD
Cefotaxime—Rash—Epirubicin—uterine cancer	0.00103	0.00106	CcSEcCtD
Cefotaxime—Dermatitis—Epirubicin—uterine cancer	0.00102	0.00106	CcSEcCtD
Cefotaxime—Headache—Epirubicin—uterine cancer	0.00102	0.00106	CcSEcCtD
Cefotaxime—Nausea—Epirubicin—uterine cancer	0.000966	0.001	CcSEcCtD
Cefotaxime—Vomiting—Doxorubicin—uterine cancer	0.000957	0.000993	CcSEcCtD
Cefotaxime—Rash—Doxorubicin—uterine cancer	0.000949	0.000985	CcSEcCtD
Cefotaxime—Dermatitis—Doxorubicin—uterine cancer	0.000948	0.000984	CcSEcCtD
Cefotaxime—Headache—Doxorubicin—uterine cancer	0.000943	0.000978	CcSEcCtD
Cefotaxime—Nausea—Doxorubicin—uterine cancer	0.000894	0.000928	CcSEcCtD
Cefotaxime—SLC15A2—lymph node—uterine cancer	0.00084	0.0233	CbGeAlD
